Regen BioPharma (RGBP) Interest Coverage Ratio (2016 - 2025)
Regen BioPharma (RGBP) has disclosed Interest Coverage Ratio for 12 consecutive years, with 1.43 as the latest value for Q3 2025.
- On a quarterly basis, Interest Coverage Ratio rose 66.37% to 1.43 in Q3 2025 year-over-year; TTM through Sep 2025 was 2.14, a 62.86% increase, with the full-year FY2025 number at 2.14, up 62.86% from a year prior.
- Interest Coverage Ratio was 1.43 for Q3 2025 at Regen BioPharma, up from 1.65 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 1.07 in Q3 2021 to a low of 574.2 in Q2 2021.
- A 5-year average of 44.08 and a median of 4.26 in 2024 define the central range for Interest Coverage Ratio.
- Peak YoY movement for Interest Coverage Ratio: crashed 74907.39% in 2021, then surged 99.66% in 2022.
- Regen BioPharma's Interest Coverage Ratio stood at 3.04 in 2021, then crashed by 779.08% to 26.72 in 2022, then surged by 74.16% to 6.9 in 2023, then skyrocketed by 64.93% to 2.42 in 2024, then soared by 40.88% to 1.43 in 2025.
- Per Business Quant, the three most recent readings for RGBP's Interest Coverage Ratio are 1.43 (Q3 2025), 1.65 (Q2 2025), and 5.08 (Q1 2025).